• 1
    Ban E, Park SH, Kang MJ, Lee HJ, Song EJ, Yoo YS. Growing trend of CE at the omics level: the frontier of systems biology—an update. Electrophoresis 2012; 33: 213.
  • 2
    Di Leo A, Claudino W, Colangiuli D, Bessi S, Pestrin M, Biganzoli L. New strategies to identify molecular markers predicting chemotherapy activity and toxicity in breast cancer. Ann Oncol 2007; 75: 384A91A.
  • 3
    Davis V, Bathe O, Schiller D, Slupsky CM, Sawyer MB. Metabolomics and surgical oncology: potential role for small molecule biomarkers. J Surg Oncol 2011; 103: 451459.
  • 4
    Amann A, Spaněl P, Smith D. Breath analysis: the approach towards clinical application. Mini Rev Med Chem 2007; 7: 115129.
  • 5
    Pauling L, Robinson AB, Teranishi R, Cary P. Quantitative analysis of urine vapour and breath by gas–liquid partition chromatography. Proc Natl Acad Sci U S A 1971; 68: 23742376.
  • 6
    Kneepkens CMF, Lepage G, Roy CC. The potential of the hydrocarbon breath test as a measure of lipid peroxidation. Free Rad Biol Med 1994; 17: 127160.
  • 7
    Toyokuni S. Molecular mechanisms of oxidative stress-induced carcinogenesis: from epidemiology to oxygenomics. IUBMB Life 2008; 60: 441447.
  • 8
    Fuchs P, Loeseken C, Schubert J, Miekisch W. Breath gas aldehydes as biomarkers of lung cancer. Int J Cancer 2010; 126: 26632670.
  • 9
    Phillips M, Cataneo RN, Saunders C, Hope P, Schmitt P, Wai J. Volatile biomarkers in the breath of women with breast cancer. J Breath Res 2010; 4: 026003.
  • 10
    Abaffy T, Duncan R, Riemen D, Tietje O, Elgart G, Milikowski C et al. Differential volatile signatures from skin, nevi and melanoma: a novel approach to detect a pathological process. PLoS One 2010; 5: e13813.
  • 11
    de Gennaro G, Dragonieri S, Longobardi F, Musti M, Stallone G, Trizio L et al. Chemical characterization of exhaled breath to differentiate between patients with malignant pleural mesothelioma from subjects with similar professional asbestos exposure. Anal Bioanal Chem 2010; 398: 30433050.
  • 12
    Qin T, Liu H, Song G, Wang HZ, Pan YY, Xiong FX et al. The screening of volatile markers for hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 2010; 19: 22472253.
  • 13
    Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 384: 14671471.
  • 14
    Ahlquist DA, Skoletsky JE, Boynton KA, Harrington JJ, Mahoney DW, Pierceall WE et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multi-target assay panel. Gastroenterology 2000; 119: 12191227.
  • 15
    de Haan MC, van Gelder RE, Graser A, Bipat S, Stoker J. Diagnostic value of CT-colonography as compared to colonoscopy in an asymptomatic screening population: a meta-analysis. Eur Radiol 2011; 21: 17471763.
  • 16
    Sobin LH, Witterkind C (eds). TNM Classification of Malignant Tumours (6th edn). Wiley-Liss: New York, 2002.
  • 17
    Dragonieri S, Schot R, Mertens JA, Le Cessie S, Gauw SA, Spanevello A et al. An electronic nose in the discrimination of patients with asthma and controls. J Allergy Clin Immunol 2007; 120: 856862.
  • 18
    Specht DF. Probabilistic neural networks and the polynomial Adaline as complementary techniques for classification. EEE Trans Neural Netw 1990; 1: 111121.
  • 19
    Kearns M, Ron D. Algorithmic stability and sanity-check bounds for leave-one-out cross-validation. Neural Comput 1999; 11: 14271453.
  • 20
    Trabue SL, Anhalt J, Zahn JA. Bias of Tedlar bags in the measurement of agricultural odorants. J Environ Qual 2006; 35: 16681677.
  • 21
    Steeghs MM, Cristescu SM, Harren FJ. The suitability of Tedlar bags for breath sampling in medical diagnostic research. Physiol Meas 2007; 28: 7384.
  • 22
    Matsubara J, Honda K, Ono M, Sekine S, Tanaka Y, Kobayashi M et al. Identification of adipophilin as a potential plasma biomarker for colorectal cancer using label-free quantitative mass spectrometry and protein microarray. Cancer Epidemiol Biomarkers Prev 2011; 20: 21952203.
  • 23
    Hibi K, Goto T, Shirahata A, Saito M, Kigawa G, Nemoto H et al. Detection of TFPI2 methylation in the serum of colorectal cancer patients. Cancer Lett 2011; 311: 96100.
  • 24
    Cordero OJ, Imbernon M, Chiara LD, Martinez-Zorzano VS, Ayude D, de la Cadena MP et al. Potential of soluble CD26 as a serum marker for colorectal cancer detection. World J Clin Oncol 2011; 2: 245261.
  • 25
    Schmutzhard J, Rieder J, Deibl M, Schwentner IM, Schmid S, Lirk P et al. Pilot study: volatile organic compounds as a diagnostic marker for head and neck tumors. Head Neck 2008; 30: 743749.
  • 26
    Gasbarrini A, Corazza GR, Gasbarrini G, Montalto M, Di Stefano M, Basilisco G et al.; 1st Rome H2-Breath Testing Consensus Conference Working Group. Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther 2009; 1: 149.
  • 27
    Marton A, Xue X, Szilagyi A. Meta-analysis: the diagnostic accuracy of lactose breath hydrogen or lactose tolerance tests for predicting the North European lactase polymorphism C/T-13910. Aliment Pharmacol Ther 2012; 35: 429440.
  • 28
    Colombo C, Faelli N, Tirelli AS, Fortunato F, Biffi A, Claut L et al. Analysis of inflammatory and immune response biomarkers in sputum and exhaled breath condensate by a multi-parametric biochip array in cystic fibrosis. Int J Immunopathol Pharmacol 2011; 24: 423432.
  • 29
    Amann A, Corradi M, Mazzone P, Mutti A. Lung cancer biomarkers in exhaled breath. Expert Rev Mol Diagn 2011; 11: 207217.
  • 30
    Westhoff M, Litterst P, Freitag L, Urfer W, Bader S, Baumbach JI. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study. Thorax 2009; 64: 744748.
  • 31
    Mazzone PJ, Hammel J, Dweik R, Na J, Czich C, Laskowski D et al. Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor assay. Thorax 2007; 62: 565568.
  • 32
    Peng G, Tisch U, Haick H. Detection of nonpolar molecules by means of carrier scattering in random networks of carbon nanotubes: toward diagnosis of diseases via breath samples. Nano Lett 2009; 9: 13621368.
  • 33
    Peng G, Hakim M, Broza YY, Billan S, Abdah-Bortnyak R, Kuten A et al. Detection of lung, breast, colorectal and prostate cancers from exhaled breath using a single array of nanonsensors. Br J Cancer 2010; 103: 542551.
  • 34
    Patterson SG, Bayer CW, Hendry RJ, Sellers N, Lee KS, Vidakovic B et al. Breath analysis by mass spectrometry: a new tool for breast cancer detection? Am Surg 2011; 77: 747751.